Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Gonadorelin

GnRH, Luteinizing Hormone-Releasing Hormone, LHRH, Factrel

A synthetic decapeptide analog of GnRH that stimulates the pituitary gland to release FSH and LH, aiding in reproductive hormone regulation and fertility treatments.

Quick Stats
Studies 192
Trials 100
Formula C55H75N17O13
Clear All
Utility 3
pubmed Sep 18, 2025

Tolerability and Shared Decision-Making in the Hormonal Management of Endometriosis-Associated Pain.

Pinto da Costa Viana. Diogo D; Jacobsen. Leonardo L; Padovesi. Igor I; Comin. Ana A; Correia. Eline...

The review looks at three hormone treatments for painful endometriosis—GnRH analogues (like gonadorelin), dienogest, and gestrinone. All work, but each has its own side‑effects: GnRH drugs drop estrogen and can hurt bone health unless you add back some hormones; dienogest keeps bone density but can cause irregular bleeding and mood changes; gestrinone is strong and easy on heart and bones but has androgenic effects that many find off‑putting. Choosing the right one depends on what side‑effects you can tolerate.

Utility 3
pubmed Oct 1, 2025

Differential Effects of Ovarian Steroids in Women With and Without Premenstrual Dysphoric Disorder: A Replication and Extension of Findings.

Wei. Shau-Ming SM; Wakim. Paul P; Martinez. Pedro E PE; Nieman. Lynnette K LK; Rubinow. David R DR;...

The study shows that turning off ovarian hormones with a GnRH agonist (leuprolide) stops the mood and physical swings of premenstrual dysphoric disorder (PMDD). When estrogen or progesterone is added back, the symptoms return, especially irritability and mood swings with progesterone. Healthy women don’t develop these symptoms when the same hormones are added back.

Utility 3
pubmed Sep 22, 2025

Successful Pregnancy in a PCOS Patient with Elevated Basal Luteinizing Hormone and Repeated Ovulation Induction Failures: A Case Report.

Fang. Ying Y; Zhao. Xuehan X; Wang. Cong C; Liu. Chang C; Liang. Yu Y; Yang. Xiaokui X

A 26‑year‑old woman with PCOS and high basal luteinizing hormone (LH) kept failing to get pregnant with standard IVF hormone protocols that used GnRH agonists or antagonists. When doctors switched to a different approach—using a progestin‑primed ovarian stimulation (PPOS) protocol together with the aromatase inhibitor letrozole and skipping any LH‑lowering pretreatment—the cycle worked and she had a healthy baby. This shows that high basal LH isn’t always a deal‑breaker for IVF, and alternative hormone regimens can rescue a failed cycle.

Utility 3
pubmed Oct 18, 2025

Sperm DNA methylation profiling in patients with Kallmann syndrome.

Wang. Rongrong R; Li. Xiaogang X; Zhang. Jingdi J; Wang. Xi X; Mao. Jiangfeng J; Feng. Xinxin X; Wan...

The study looked at men with Kallmann syndrome and found that their sperm DNA has many extra chemical tags (methyl groups) compared to healthy men. Some of these changes are linked to genes that control brain development, hormone release, and sperm production. After treatment with GnRH or gonadotropins, the DNA still shows these changes, and they are tied to poorer semen quality.

Utility 3
pubmed 2025

Metabolic safety of gender-affirming hormonal treatment in transgender females.

Milionis. Charalampos C; Barouti. Konstantina K; Papadopoulou. Vassiliki V; Pouliasi. Foteini F; Kar...

A study of transgender women who took oral estradiol and a GnRH‑agonist (similar to gonadorelin) for about a year and a half showed that the hormone mix kept estrogen and testosterone in the desired range, but it did raise triglyceride levels a bit and lowered red‑blood‑cell counts, though not enough to cause serious problems. Other health markers like cholesterol, blood sugar, and liver enzymes stayed stable.

Utility 3
pubmed Oct 3, 2025

Kuntai capsule for the treatment of menopausal symptoms induced by GnRH-a therapy: A systematic review and meta-analysis of randomized controlled trials.

Yu. Junhong J; Yu. Fanya F; Zhang. Lina L; Zhang. Xudong X; Zhang. Juwen J; Zhang. Yangyang Y; Xiong...

A large review of 36 Chinese trials (3,577 women) found that taking the herbal Kuntai capsule together with GnRH‑agonist drugs (like gonadorelin) cuts menopausal‑type side effects—hot flashes, trouble sleeping and vaginal dryness—by about half and improves overall symptom scores.

Utility 2
pubmed Nov 22, 2025

Efficacy of Dienogest Versus GnRH Agonists After Endometriosis Surgery: A Systematic Review and Meta-Analysis.

Servidoni. Ana Clara Pimenta ACP; Martin. Giovanna de Castro GC; Gaio. Giovana de Souza GS; Amador....

Both dienogest and GnRH agonists (like gonadorelin) work about the same for pain relief and preventing endometriosis lesions after surgery, but they have different side‑effects: dienogest often causes more vaginal bleeding, while GnRH agonists tend to cause hot flushes.

Utility 2
pubmed Nov 3, 2025

Racial Differences in Adverse Events After Androgen Deprivation in Veterans With Prostate Cancer.

Friedrich. Nadine A NA; Janes. Jessica L JL; Parrish. Joshua J; De Hoedt. Amanda M AM; Josan. Kiranb...

A huge study of US veterans with prostate cancer found that drugs that shut down testosterone production (like leuprolide, goserelin, or triptorelin) raise the chances of heart problems, bone fractures, and osteoporosis for everyone, no matter their race. Black men had a slightly smaller jump in heart risk but a bigger jump in osteoporosis risk compared to White men, but the differences were modest.

Utility 2
pubmed Nov 24, 2025

Central administration of docosahexaenoic acid, eicosapentaenoic acid, or linoleic acid activates hypothalamic fatty acid sensing and is involved in reproductive regulation in spotted scat (Scatophagus argus).

Wang. Siqin S; Luo. Jie J; Lin. Xinghua X; Lin. Tin T; Shi. Hongjuan H; Jiang. Dongneng D; Wu. Tianl...

In a fish study, giving the brain DHA, EPA, or linoleic acid changed the activity of a fatty‑acid sensor (CD36) and a hormone‑regulating protein (PPARα). This, in turn, altered the levels of the fish's own GnRH genes, which control reproduction. Blocking the sensor or the PPARα pathway reduced these effects, showing the fatty acids act through that route.

Utility 2
pubmed Nov 12, 2025

Comparative Efficacy of GnRHa Monotherapy vs. Combination Therapy for Central Precocious Puberty: A Systematic Review and Meta-Analysis.

Tsai. Chang-En CE; Fan. Hsien-Yu HY; Tsai. Meng-Che MC; Chang. Hsin-Yuan HY; Lin. Chien-Ming CM; Yan...

A big review looked at kids with early puberty and compared using just a GnRH drug (like gonadorelin) versus adding other hormones such as growth hormone, stanozolol, oxandrolone, or estrogen. Adding growth hormone gave kids a few extra centimeters of predicted adult height and faster growth, but the studies were quite mixed and not all the data were solid. Other drugs showed some promise, but there isn’t enough evidence yet. The benefits were bigger when treatment lasted longer or used higher growth‑hormone doses.

Utility 2
pubmed Nov 23, 2025

Psychosocial stress in women with functional hypothalamic amenorrhea and potential implications for cardiovascular disease risk.

Klejc. Kamelia K; Safwan. Nancy N; Stouffer. Kelly K; Berga. Sarah S; Andrade. Maria D Hurtado MDH;...

The review explains that women who stop having periods because of stress, intense exercise, or not eating enough (called functional hypothalamic amenorrhea) have low estrogen, high cortisol, and thyroid changes that can damage blood vessels and raise long‑term heart disease risk. Stress itself—not just low estrogen—is a big driver of these problems.

Utility 2
pubmed Dec 1, 2025

Identifying nutraceutical targets to treat polycystic ovary syndrome using graph representation learning.

Hanassab. Simon S; Southern. Joshua J; Olabode. Ayomide V AV; Laponogov. Ivan I; Bronstein. Michael...

Researchers used machine‑learning to scan large data sets and found that compounds in green tea (epicatechin‑3‑gallate) and almonds might help with PCOS by reducing inflammation and androgen levels. They also confirmed that drugs that affect the gonadotropin‑releasing hormone (GnRH) receptor, like gonadorelin, are linked to PCOS pathways, which matches what we already know.

Utility 2
pubmed Nov 12, 2025

Age-stratified analysis of euploidy rates in Progestin-Primed Ovarian Stimulation (PPOS) utilizing micronized progesterone or dydrogesterone versus GnRH analogues.

Liu. Rang R; Pan. Xinyi X; Wang. Yutong Y; Xiang. Rui R; Zhuang. Shaohong S; Diao. Xiaoting X; Fang....

The study looked at whether the type of hormone used to stimulate egg production (either progesterone‑based or traditional GnRH drugs) changes the chance that embryos have the right number of chromosomes. Across different age groups, the type of drug didn’t matter – age was the only thing that affected chromosome quality.

Utility 2
pubmed Dec 2, 2025

Effects of GnRH agonists and antagonists on cardiovascular and metabolic systems in adults: Mechanistic pathways and risk management.

Etezadi. Atoosa A; Marashi. Seyed Mehdi SM; Nazari. Leila L; Sina. Mozhgan M; Samadi Nasab. Fatemeh...

GnRH drugs, which are used for things like fertility problems and some cancers, can mess up your metabolism and heart health. They can make you more insulin‑resistant, raise bad cholesterol, and cause extra belly fat that fuels inflammation, all of which raise the chance of diabetes and heart disease. The biggest warning is for people on these drugs for a long time, especially adults, while we still don’t know much about the effects on kids.

Utility 2
pubmed Oct 24, 2025

Effects of hormonal treatment on the expression of collagen type I, matrix metalloproteinase-1, and tissue inhibitor of metalloproteinases-1 in endometriosis.

Matsuzaki. Sachiko S; Canis. Michel M

Hormone therapies like combined oral contraceptives, progestins, and GnRH agonists (the same class as gonadorelin) can shrink the scar‑like tissue (fibrosis) in deep infiltrating endometriosis, but they don’t change the fibrous tissue in ovarian endometrioma.

Utility 2
pubmed Nov 4, 2025

Recent findings on psychosocial outcomes of gender-affirming medical care for transgender youth.

Weixel. Tara T; Whitehead. Jax J; Chen. Diane D

Recent long‑term studies show that using GnRH agonists (like gonadorelin) to pause puberty, followed by gender‑affirming hormone therapy, helps transgender youth feel better mentally and reduces gender‑related distress. The benefits are tied to comprehensive, supportive care rather than the drug alone.

Utility 2
pubmed Oct 30, 2025

Effect of kisspeptin, neurokinin, and dynorphin neurons on regulation of reproduction.

Racková. Jana J

The brain has special cells called KNDy neurons that release three chemicals—kisspeptin, neurokinin B, and dynorphin—to control the timing and strength of GnRH (gonadorelin) pulses, which drive reproductive hormones. Hormones like estrogen, progesterone, and testosterone can also feed back onto these neurons, affecting puberty, menstrual cycles, and fertility issues.

Utility 2
pubmed Oct 29, 2025

The Effects of FSH Versus GnRH Vaccination on Growth Performance and Meat Quality of Surgically Castrated Male Growing-Finishing Pigs.

Wang. Ganchuan G; Zhou. Junhua J; Lv. Gang G; Jiang. Xuemei X; Song. Chenling C; Hua. Lun L; Wang. C...

In a pig study, vaccinating against the hormone FSH made the animals eat more efficiently and store less fat, while also changing some meat quality traits. The effect was stronger than a similar vaccine against GnRH. However, the work was done in castrated male pigs, not people, so the findings are only a hint that lowering FSH might affect body fat.